高频振荡通气联合肺表面活性物质治疗新生儿肺出血的疗效观察

林新祝; 赖基栋; 吕梅; 祝垚; 王恋; 陈超

doi:10.7499/j.issn.1008-8830.2015.04.011

PDF(1326 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (4) : 345-349. DOI: 10.7499/j.issn.1008-8830.2015.04.011

论著·临床研究

高频振荡通气联合肺表面活性物质治疗新生儿肺出血的疗效观察

林新祝¹, 赖基栋¹, 吕梅¹, 祝垚¹, 王恋¹, 陈超²

作者信息 +

Clinical efficacy of high-frequency oscillatory ventilation combined with pulmonary surfactant in treatment of neonatal pulmonary hemorrhage

LIN Xin-Zhu¹, LAI Ji-Dong¹, LV Mei¹, ZHU Yao¹, WANG Lian¹, CHEN Chao²

Author information +

文章历史 +

摘要

目的探讨高频振荡通气(HFOV)联合肺表面活性物质(PS)治疗新生儿肺出血(NPH)的临床疗效。方法将2010 年1 月至2014 年6 月确诊为NPH 的122 例患儿,按胎龄分层后,随机分为HFOV+PS 治疗组(简称试验组)和单纯HFOV 治疗组(简称对照组),每组61 例。两组患儿均在发生NPH 后行HFOV,试验组在行HFOV 后2~4 h 给予气管内注入PS,然后继续HFOV。观察两组患儿上机时及上机后6、12、24 h 的血气分析、OI 值、PaO₂/FiO₂(P/F)值的动态变化,比较两组患儿的肺出血时间、上机时间、并发症和治愈率。结果试验组在上机后6、12、24 h 的PaO₂、PaCO₂、OI 值、PaO₂/FiO₂(P/F)值均要优于对照组(P<0.05);试验组的肺出血停止时间及上机时间均短于对照组(P<0.01),且并发症发生率低于对照组(P<0.05);试验组治愈率(87%)与对照组(82%)相比差异无统计学意义(P>0.05)。结论 HFOV 联合PS 治疗NPH 可以改善氧合,缩短NPH 时间及上机时间,减少并发症的发生,但与单纯HFOV 相比并不能降低病死率。

Abstract

Objective To explore the clinical efficacy of high-frequency oscillatory ventilation (HFOV) combined with pulmonary surfactant (PS) in the treatment of neonatal pulmonary hemorrhage (NPH). Methods A total of 122 neonates diagnosed with NPH between January 2010 and June 2014 were enrolled. After being stratified by gestational age, the neonates were randomly divided into treatment (HFOV+PS) and control (HFOV alone) groups (n=61 each). Both groups were treated with HFOV after the onset of NPH. After 2-4 hours of HFOV treatment, the treatment group received PS via intratracheal injections, followed by continuous use of HFOV. Dynamic changes in the blood gas, oxygenation index (OI), and PaO₂/FiO₂ (P/F) values of the neonates were determined before HFOV treatment and after 6, 12, and 24 hours of HFOV treatment. The time to hemostasis, duration of ventilation, incidence of complications, and cure rate were compared between groups. Results After 6, 12, and 24 hours of HFOV treatment, the treatment group had significantly improved PaO₂, PaCO₂, O/I, and P/F values compared with the control group (P<0.05). The time to hemostasis and the duration of ventilation were significantly shorter in the treatment group than in the control group (P<0.01), and the incidence of complications was lower in the former than in the latter (P<0.05). There was no significant difference in the cure rate between the treatment (87%) and control (82%) groups (P>0.05). Conclusions HFOV combined with PS is an effective treatment to improve oxygenation, shorten the time to hemostasis and the duration of ventilation, and reduce the incidence of complications in neonates with NPH. However, the dual therapy is unable to reduce the mortality of neonates compared with HFOV monotherapy.

导出引用

林新祝, 赖基栋, 吕梅, 祝垚, 王恋, 陈超. 高频振荡通气联合肺表面活性物质治疗新生儿肺出血的疗效观察[J]. 中国当代儿科杂志. 2015, 17(4): 345-349 https://doi.org/10.7499/j.issn.1008-8830.2015.04.011

LIN Xin-Zhu, LAI Ji-Dong, LV Mei, ZHU Yao, WANG Lian, CHEN Chao. Clinical efficacy of high-frequency oscillatory ventilation combined with pulmonary surfactant in treatment of neonatal pulmonary hemorrhage[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(4): 345-349 https://doi.org/10.7499/j.issn.1008-8830.2015.04.011

参考文献

[1] 史源, 李华强. 新生儿肺止血的格床问题[J]. 实用儿科临床杂志, 2005, 20(10): 1055-1056.
[2] Dufourq N, Thomson M, Adhikari M, et al. Massive pulmonary hemorrhage as a cause of death in the neonate: a retrospective review[J]. S Afr Med J, 2004, 94(4): 299-302.
[3] 陈丹, 黄西林, 李小萍, 等. 高频振荡通气治疗新生儿肺出血的临床研究[J]. 临床儿科杂志, 2011, 29(3): 212-215.
[4] Neumayr TM, Watson AM, Wylam ME. Surfactant treatment of an infant with acut eidiopathic pulmonary hemorrhage[J]. Pediatr Crit Care Med, 2008, 9(1): e4-e6.
[5] 中华医学会儿科学分会新生儿学组. 新生儿肺出血的诊断与治疗方案[J]. 中华儿科杂志, 2001, 39(4): 248.
[6] 陈克正, 张喆. 新生儿肺出血的病因分析[J]. 中国新生儿科杂志, 2008, 23(1): 3-7.
[7] 陈超. 肺出血[M]//邵肖梅, 叶鸿瑁, 邱小汕. 实用新生儿学. 第4 版. 北京: 人民卫生出版社, 2011: 408-411.
[8] 陈克正, 王卫, 吕回. 新生鼠出血肺组织病理与氧自由基关系[J]. 小儿急救医学, 2002, 9(4): 207-208.
[9] 蔡栩栩, 毛健, 辛颖, 等. 新生儿肺出血支气管肺泡灌洗液 SP-A 及TNF-α 的变化及其相关性研究[J]. 中国当代儿科杂志, 2005, 7(3): 198-201.
[10] Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates[J]. Cochrane Database Syst Rev, 2012, 7: CD005254.
[11] Yen TA, Wang CC, Hsieh WS, et al. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants[J]. Pediatr Neonatol, 2013, 54(5): 330-334.
[12] Rennie JM 著, 刘锦纷译. 罗伯顿新生儿学[M]. 第4 版. 北京: 北京大学医学出版社, 2009: 561-564.
[13] 潘荣华, 张士发, 邰海服, 等. 肺表面活性物质治疗足月新生儿肺出血的临床研究[J]. 药物治疗学, 2014, 19(4): 454-458.
[14] Meena N, Meena K, Jonathan B, et al. The use of extracorporeal membrane oxygenation, high-frequency oscillatory ventilation, and surfactant for the management of intraoperative acute pulmonary hemorrhage in tetralogy of Fallot[J]. J Cardiothorac Vasc Anesth, 2011, 25(2): 313-315.